WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 6'7201 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 17'6151 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 9'308  9'357  9'405  9'450  9'491  9'981  10'260  9'659 
Births 102  103  103  104  104  88  143  157 
Surviving infants 101  102  103  103  103  87  141  154 
Pop. less than 5 years 515  521  526  523  509  461  807  745 
Pop. less than 15 years 1'444  1'432  1'423  1'416  1'409  1'861  2'367  2'210 
Female 15-49 years 2'304  2'343  2'382  2'421  2'459  2'637  2'482  2'502 

Number of reported case

(Click for retrospective incidence data for Belarus)
Diphtheria 52  22 
Japanese encephalitis
Measles 64  16  10  50  21  224 
Mumps 61  48  88  19'069 
Pertussis 378  188  576  151  112  169  462 
Polio*
Rubella 10  20  16'034 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Belarus)
Vaccine year result method % card seen                                                
BCG          99  99  98  99  99  99 
DTP1          97  99  99  99  97 
DTP3          97  98  98  99  98  99 
HepB_BD          99  99  98  98  98 
HepB3          97  98  97  98  96  70 
Hib3          99  98  99  99*  93 
JapEnc         
MCV          99  99  98  99  99  98 
MCV2          98  99  97  99  99  92 
PCV1          99* 
PCV3          86 
Pol3          97  98  98  99  99  99 
Rota1         
Rota_last         
Rubella1          99  99  98  99  99 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Belarus)
BCG 99  98  99  99  99 
DTP1 99  98  99  99  99 
DTP3 98  98  98  98  99 
HepB3 98  97  98  96  70 
HepB_BD 99  98  98  98 
Hib3 23  22  21 
MCV 99  98  99  99  98 
MCV2 99  97  99  99  92 
PCV3
Pol3 98  98  98  99  99 
Rota_last

Number of districts in the country 121  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3-5 days; 7 years; Yes
DT 6 years; Yes
DTaPIPV 3, 4, 5,18 months; Yes
DTwP 3, 4, 5, 18 months; Yes
HIB 3, 4, 5, 18 months; Yes risk groups
HepB_pediatric 1 day; 1, 5 months; Yes
IPV 3, 4, 5 months; Yes
Influenza >= 6 months; Yes
MMR 12 months; 6 years; Yes
OPV 18, 24 months; 7 years; Yes
Pneumo_conj 2, 4, 12, 14 months; Yes risk groups
TT No emergencies prophylactics
Td 16, 26, 36, 46, 56, 66 years; Yes
Tdap 11 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number     2007-2012  2007-2012  2007-2012  2007-2012  2007-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 121    121         

System performance

Total Nº districts in country number 121  131  121  130  130  119  119 
Nº districts with DTP3 coverage >=80% number 121  121  121  130  130  119  119 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  92  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 121  121  121  130  130  119  119 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  92  100  100  100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   NA    97  97  98  98 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.